A NEW DOSIMETRY DEVICE FOR QUANTIFICATION OF RADIATION

    公开(公告)号:US20210286093A1

    公开(公告)日:2021-09-16

    申请号:US17257729

    申请日:2019-06-28

    Abstract: Provided herein is a dosimetry device for quantifying the dosage of radiation emitted from a radiation source, the device comprising: (i) a radiation dose indicator; (ii) an optical means to capture the color change; and (iii) a software means to compare the optical density of the dose indicator as compared to a predetermined calibration curve. Also provided herein is a method of quantifying the dosage of radiation emitted from the radiation source. Further provided herein is use of said dosimetry device in various medical, food and industrial applications.

    LACTAMIC POLYMER CONTAINING AN ACETOACETATE MOIETY
    5.
    发明申请
    LACTAMIC POLYMER CONTAINING AN ACETOACETATE MOIETY 审中-公开
    含有乙酰乙酸酯环糊精的乳酸聚合物

    公开(公告)号:US20170022313A1

    公开(公告)日:2017-01-26

    申请号:US15287919

    申请日:2016-10-07

    Abstract: The invention provides lactamic polymers comprising an acetoacetate moiety. The lactamic polymers may be readily functionalized and the functionalized lactamic polymers may be further derivatized to provide a wide variety of useful polymers having desirable chemical and physical properties. The lactamic polymers of the invention may be employed in a wide variety of compositions. (A); (B) wherein R1-R6, w, x, y, z, and n are described herein.

    Abstract translation: 本发明提供了包含乙酰乙酸酯部分的内酰胺聚合物。 内酰胺聚合物可以容易地官能化,并且功能化的内酰胺聚合物可以被进一步衍生化,以提供具有期望的化学和物理性质的多种有用的聚合物。 本发明的内酰胺聚合物可用于多种组合物中。 (一个); (B)其中R1-R6,w,x,y,z和n在本文中描述。

    PROLIFEROUS COPOLYMERS COMPRISING LACTAMIC MOIETIES

    公开(公告)号:US20180340034A1

    公开(公告)日:2018-11-29

    申请号:US15777691

    申请日:2016-11-21

    Inventor: David K. HOOD

    Abstract: This invention relates to the preparation and utility of proliferous polymer compositions comprising repeating units derived from (a) a monomer comprising at least one functionalized or unfunctionalized acryloyl moiety and at least one lactam moiety, (b) an optional monomer comprising at least one double bond, and (c) a at least one cross-linker.

Patent Agency Ranking